DermTech, Inc.

DermTech, Inc. (Nasdaq: DMTK) is a San Diego-based precision dermatology company that entered the public markets through a SPAC business combination, completing its merger in 2019 and subsequently trading on Nasdaq under the DMTK ticker. The company operates in the healthcare and molecular diagnostics sector, developing non-invasive genomic skin tests, including its Smart Sticker platform designed for early melanoma detection. The 10-Q referenced here, filed with the SEC on August 10, 2018 under accession number 0001144204-18-043607, reflects a pre-combination reporting period ahead of the SPAC transaction close. Sign up at SpacDesk for full filing history, sponsor data, and deal analytics on DMTK and hundreds of other SPAC transactions.